Agency for Care Effectiveness (ACE)

Stroke remains a leading cause of death and disability worldwide, but early recognition and preventive care can save lives. Patients with atrial fibrillation are at a higher risk of having stroke. Explore our patient factsheet on oral anticoagulants and find out how these treatments reduce the risk of stroke by preventing blood clots: https://go.gov.sg/aceli267 Healthcare professionals can explore our ACE Clinical Guidance (ACG) Oral anticoagulation for atrial fibrillation and access essential information on optimising anticoagulation treatment and preventing strokes: https://go.gov.sg/aceli268 Together, let’s enhance patient care and health outcomes. #WorldStrokeDay #StrokeAwareness #ACE

🎥 Throwback to the ACE Value-Based Healthcare Conference 2024! 🌟 Missed the event? Don’t worry, we’ve captured the best moments just for you! From impactful keynote speeches to engaging panel discussions, this year's event brought together global healthcare professionals and thought leaders to discuss the future of value-based healthcare. 🌐 🚀 Watch our event highlight reel to relive the dynamic conversations and insights that are driving the transformation of healthcare and let us know which topics resonated with you the most. 💬 👉 Check out the key moments here: go.gov.sg/aceli270 #ACEVBHC2024 #TransfromingHealthcare #ValueBasedCare #HealthcareInnovation #ConferenceRecap #EventHighlights

Meet our Medical Technology Evaluation Specialist, Dr Wayne Ding. Swipe to find out how Wayne ensures that healthcare remains affordable and accessible through his work in evaluating medical technologies and informing funding decisions. Learn how his efforts at ACE are improving access to cost-effective treatments for patients across Singapore: https://go.gov.sg/aceli266 #ACE #ACEHTA #LifeAtACE #StaffFeature #SingaporeHealthcare

ACE’s 2024 call for clinical topic(s) submission is NOW OPEN! ACE would like to invite all medical practitioners from public and private healthcare institutions to submit clinical topic(s) to be considered for development into ACE Clinical Guidances (ACGs). Only submissions via the online form will be accepted from 21 October to 18 November 2024. Find out more and submit your clinical topic(s) here: https://lnkd.in/garzawx4 To learn more about our ACGs, click here: https://go.gov.sg/aceli265

📊 ACE develops clinical guidance and educational resources to support healthcare professionals and patients to receive effective, evidence-based care. On World Evidence-Based Healthcare Day, we highlight the importance of using scientific evidence to improve patient health outcomes through clinical guidance. Our ACE Clinical Guidances (ACGs) undergo a rigorous development process where recommendations are formulated based on the identification and appraisal of high-quality evidence at the time of development. Explore our ACGs today: https://go.gov.sg/aceli264 #ACE #ClinicalGuidance #WorldEvidenceBasedHealthcareDay #EvidenceBasedHealthcare

Osteoporosis is a skeletal disease in which bone density and quality are reduced. This World Osteoporosis Day, we highlight the important role healthcare professionals play in identifying and managing osteoporosis early, helping patients stay fracture-free. Our ACE Clinical Guidance (ACG) on Osteoporosis — identification and management in primary care provides evidence-based recommendations to support healthcare professionals in osteoporosis risk assessment and correct diagnosis to ensure delivery of effective osteoporosis care. For more information, download our ACG here: https://go.gov.sg/aceli263 Note: The ACG is currently being updated, do look out for our publication announcement! 😊 #ACE #WorldOsteoporosisDay #OsteoporosisAwareness #BoneHealth 

ACE’s Consumer Engagement and Education (CEE) team had the privilege to attend the SG Ostomy Awareness Day 2024, jointly organised by the Ostomy Association of Singapore (OAS) and Singapore General Hospital (SGH) on 12 October 2024. The event featured excellent volunteer performances, and healthcare professionals delivered insightful presentations on using #stomas to manage #colorectal conditions and addressing stoma-related complications. Inspiring stories were also shared by patients and carers, highlighting their experiences of living with or caring for someone with a stoma. We appreciated the opportunity to participate in SG Ostomy Awareness Day 2024 and would like to congratulate Ellil Mathiyan Lakshmanan and the OAS and SGH teams on the successful event. We look forward to future collaborations to further improve healthcare in Singapore. Find out more about CEE’s activities from our CEE updates: https://go.gov.sg/aceli269

Meet Mr Jessie James Gonzales, a customer service professional in his thirties, who has experienced improvements in his health with subsidised treatment for relapsing-remitting multiple sclerosis (RRMS). RRMS is a form of multiple sclerosis characterised by episodes of attacks (relapses). Symptoms can include fatigue, slurred speech, numbness or tingling, blurred vision, problems with movement, bladder control, thinking, concentration and memory. This can be followed by periods of partial or complete recovery (remission). After experiencing frequent relapses and worsening symptoms that affected his mobility and daily activities, Jessie was prescribed fingolimod, a disease-modifying therapy for RRMS. Through ACE’s evaluation, fingolimod has been recommended by the Drug Advisory Committee for inclusion on the Medication Assistance Fund (MAF) for treating adults and children with RRMS. The subsidy significantly reduced Jessie’s out-of-pocket expenses, allowing him to manage his condition without an overwhelming financial burden. Read our guidance on disease-modifying therapies for treating multiple sclerosis at: https://go.gov.sg/aceli245

🌍 This World Spine Day, we’re highlighting how ACE’s clinical and HealthTech guidances support healthcare professionals in delivering effective, evidence-based, and accessible treatments for musculoskeletal conditions. Did you know that spinal implants were added to the MOH Implant Subsidy List (ISL) starting 26 July 2024? The MOH ISL-listed spinal implants have been evaluated to be both clinically and cost effective, making spinal fixation treatments more accessible for eligible patients in Singapore. For healthcare professionals ordering MRI of the lumbar spine, the ACE Clinical Guidance (ACG) on When to order MRI for low back pain features key evidence-based recommendations on the role of MRI of the lumbar spine for low back pain that is non-specific or linked to a specific spinal pathology. 👉 Explore our HealthTech guidance on integrating acupuncture into pain management and the subsidised treatments available for symptomatic lumbar disc degenerative disease (DDD) https://go.gov.sg/aceli259  👉 Learn about the ACG recommendations for when to order MRI for low back pain https://go.gov.sg/aceli260 👉 Explore more about the MOH Spine Implants Listing: https://go.gov.sg/aceli261 👉 Check out our patient factsheet on biologic treatments for axial spondyloarthritis: https://go.gov.sg/aceli262 #ACE #WorldSpineDay #Acupuncture #LowBackPain #LumbarDisc #DDD #HealthcareProfessionals #SupportYourSpine #SpinalHealth

✨ Celebrating Innovation in Healthcare! 🎉 We are thrilled to share our top 9 HealthTech Guidances! From enhancing patient outcomes to supporting value-based care, these resources empower both healthcare professionals and patients alike. 💪💙 Explore how these innovative solutions are driving better healthcare for all. https://go.gov.sg/aceli258 #ACE #MedTech #Healthcare #Singapore